organization · Reporting owner
GG 1978 SICAF SIF S.A.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Royalty Pharma plcRPRX · Entity 3100 | 10% owner | September 20, 2022 | September 22, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Royalty Pharma plc
Report date September 20, 2022 · Filed September 22, 2022
Jointly reported with GG 1978 SICAF SIF S.A. - GG Strategic
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectSee Footnotes | 21,426,170 |
Reported balance
After 2022-09-20 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2022-09-20 · Sale · Disposed 267,815 · Balance 21,426,170 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.61 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic ("GG Strategic"). F2: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic ("GG Strategic").
F2: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust.
F3: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.61 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2022 Filed Sep 22, 2022 16:30 UTC | Royalty Pharma plc RPRX · Entity 3100 | SaleClass A Ordinary Shares | 267,815 | $41.02 | $10,985,798.08 |
DisclosureSEC source: 0001140361-22-034414 · form4.xml · nonDerivative · entry 1 GG 1978 SICAF SIF S.A. - GG Strategic · CIK 0001814890 · 10% owner GG 1978 SICAF SIF S.A. · CIK 0001814891 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 21,426,170 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.61 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic ("GG Strategic"). F2 · ownership.nature: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3 · ownership.nature: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. Read SEC document |
| September 19, 2022 Filed Sep 20, 2022 16:30 UTC | Royalty Pharma plc RPRX · Entity 3100 | SaleClass A Ordinary Shares | 232,185 | $41.50 | $9,635,654.28 |
DisclosureSEC source: 0001140361-22-034011 · form4.xml · nonDerivative · entry 2 GG 1978 SICAF SIF S.A. - GG Strategic · CIK 0001814890 · 10% owner GG 1978 SICAF SIF S.A. · CIK 0001814891 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 21,693,985 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.99 to $41.77 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic ("GG Strategic"). F2 · ownership.nature: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3 · ownership.nature: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 16:30 UTC | Royalty Pharma plc RPRX · Entity 3100 | SaleClass A Ordinary Shares | 154,986 | $41.72 | $6,466,279.40 |
DisclosureSEC source: 0001140361-22-034011 · form4.xml · nonDerivative · entry 1 GG 1978 SICAF SIF S.A. - GG Strategic · CIK 0001814890 · 10% owner GG 1978 SICAF SIF S.A. · CIK 0001814891 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 21,926,170 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.32 to $42.06 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic ("GG Strategic"). F2 · ownership.nature: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3 · ownership.nature: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 17:05 UTC | Royalty Pharma plc RPRX · Entity 3100 | SaleClass A Ordinary Shares | 154,154 | $42.26 | $6,514,918.01 |
DisclosureSEC source: 0001140361-22-033641 · form4.xml · nonDerivative · entry 2 GG 1978 SICAF SIF S.A. · CIK 0001814891 · 10% owner GG 1978 SICAF SIF S.A. - GG Strategic · CIK 0001814890 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 22,081,156 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.08 to $42.65 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic (formerly known as Nogra Group SICAF SIF GG Strategic) ("GG Strategic"). F2 · ownership.nature: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3 · ownership.nature: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 17:05 UTC | Royalty Pharma plc RPRX · Entity 3100 | SaleClass A Ordinary Shares | 190,860 | $42.48 | $8,108,133.61 |
DisclosureSEC source: 0001140361-22-033641 · form4.xml · nonDerivative · entry 1 GG 1978 SICAF SIF S.A. · CIK 0001814891 · 10% owner GG 1978 SICAF SIF S.A. - GG Strategic · CIK 0001814890 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 22,235,310 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.275 to $42.88 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic (formerly known as Nogra Group SICAF SIF GG Strategic) ("GG Strategic"). F2 · ownership.nature: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3 · ownership.nature: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 16:17 UTC | Royalty Pharma plc RPRX · Entity 3100 | SaleClass A Ordinary Shares | 248,006 | $42.86 | $10,629,958.77 |
DisclosureSEC source: 0001140361-22-032905 · form4.xml · nonDerivative · entry 2 GG 1978 SICAF SIF S.A. - GG Strategic · CIK 0001814890 · 10% owner GG 1978 SICAF SIF S.A. · CIK 0001814891 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 22,426,170 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.395 to $43.155 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic (formerly known as Nogra Group SICAF SIF GG Strategic) ("GG Strategic"). F2 · ownership.nature: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of each of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3 · ownership.nature: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 16:17 UTC | Royalty Pharma plc RPRX · Entity 3100 | SaleClass A Ordinary Shares | 250,000 | $42.53 | $10,632,575.00 |
DisclosureSEC source: 0001140361-22-032905 · form4.xml · nonDerivative · entry 1 GG 1978 SICAF SIF S.A. - GG Strategic · CIK 0001814890 · 10% owner GG 1978 SICAF SIF S.A. · CIK 0001814891 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 22,674,176 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.09 to $42.83 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic (formerly known as Nogra Group SICAF SIF GG Strategic) ("GG Strategic"). F2 · ownership.nature: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of each of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3 · ownership.nature: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 17:41 UTC | Royalty Pharma plc RPRX · Entity 3100 | SaleClass A Ordinary Shares | 1,994 | $44.00 | $87,736.00 |
DisclosureSEC source: 0001140361-22-031350 · form4.xml · nonDerivative · entry 1 GG 1978 SICAF SIF S.A. - GG Strategic · CIK 0001814890 · 10% owner GG 1978 SICAF SIF S.A. · CIK 0001814891 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 22,924,176 F1 · ownership.nature: Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic (formerly known as Nogra Group SICAF SIF GG Strategic) ("GG Strategic"). F2 · ownership.nature: GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of each of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust. F3 · ownership.nature: Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.